Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 3.8

From GxPlex

Revision as of 17:29, 15 July 2026 by imported>GxPlexBot (Import from GxPlex Excel)
Jump to: navigation, search



Document information
Reference ICH ICH E6 Guideline R3 (2025)
Validity area ICH
Scope(s) HM
Document name ICH E6 Guideline
Version / Revision R3 (2025)
Status Current
Document type International guideline
Language(s) EN
Description GUIDELINE FOR GOOD CLINICAL PRACTICE
Official source Official link
Restricted access No
Submitted by Florian Adragna
Contributors


Reference Details
Module Module 1 — Unit 1.5.4
Scope G
Document part III. Annex 1

3.8

Language EN
Original entry by Florian Adragna
Contributors
Tags Sponsor, Ethics committee, Competent authority, Sponsor safety reporting, Regulatory submission
Comment Sponsor communication with IRB/IEC and regulatory authority

Content

3. SPONSOR [...] 3.8 Communication with IRB/IEC and Regulatory Authority(ies) 3.8.1 Notification/Submission to Regulatory Authority(ies) In accordance with applicable regulatory requirement(s), before initiating the clinical trial(s), the sponsor (or the sponsor and the investigator) should submit any required application(s) to the appropriate regulatory authority(ies) for review, acceptance and/or permission to begin the trial(s). Any notification/submission should be dated and contain sufficient information to identify the protocol.

3.8.2 Confirmation of Review by IRB/IEC (a) Where reference is made to a submission to the IRB/IEC, this can be made by the investigator/institution or sponsor in accordance with applicable regulatory requirements (see section 1.1). (b)The sponsor should ensure that the following is obtained:

  (i) The name and address of the relevant IRB/IEC along with:
        (aa) A statement that it is organised and operates according to GCP and the applicable regulatory requirements;
        (bb) Documented initial and subsequent IRB/IEC approval/favourable opinion as well as any termination of the trial or the suspension of approval/favourable opinion.